HOME » About Us » Leadership Team » Management Team

    Management Team


    Venkateswarlu Nelabhotla (N. Venkat), CEO & Board Member

    Venkat comes with a very rich and global experience of successfully leading organizations in the Life sciences and Consumer Products businesses. He has held top management roles in the life sciences space in companies like Shantha Biotech (A Sanofi Company) and Aurobindo Pharma and he immensely contributed to their all-round growth. Shantha Biotech - a biosimilar and vaccine company, was eventually acquired by Sanofi for around $ 800 MN in 2010. He has been a part of significant revenue growth and significant value creation in Aurobindo Pharma in the global business segment of APIs and finished dosage form products in multiple therapy areas.

    He has held CEO roles in Emami and Cavinkare, CPG companies, growing them significantly with an all rounded approach. During his stint at Emami (a listed company) as CEO, the company's value went up by 4 times within 3 years. The momentum thus created, has made Emami a large market cap FMCG company in India now. During early part of his career, he created some very successful brands in Cavinkare, a leading CPG company from India, and built the organization with a 10X revenue increase in 6 years’ time and that early momentum has made Cavinkare one of the established Consumer product companies in India. He comes with core strengths in Strategy, Innovation, Marketing, Organization building, Finance, M&A and Governance. He has been an integral part of many industrial forums in Life sciences and CPG business.

    Contact information: nvenkat@vyome.in


    Dr. Shiladitya Sengupta, Board Member

    Dr. Shiladitya Sengupta is an assistant professor of medicine at Harvard Medical School. He is also the Co-Founder of Invictus Oncology, Cerulean Pharmaceuticals and Mitra Biotech. Shiladitya's research focuses on the development of novel nanomedicines for cancer and angiogenesis-based diseases. In 2005, he was recognized as one of the top 35 innovators worldwide by MIT Technology Review magazine. He has also received the Shakuntala Amir Chand Award from the Indian Council for Medical Research.

    Shiladitya is an alumnus of the All India Institute of Medical Sciences, and completed his PhD as a Nehru Scholar from Trinity College at Cambridge University and was a Fellow at MIT before joining Harvard. He has published over 35 papers, including in Nature and Proceedings of the National Academy of Sciences.


    Dr. Angelo Secci, Chief Medical Officer

    Dr. Angelo Secci is a seasoned clinical research and development professional with over two decades of experience. His experience in various therapeutic areas such as Dermatology, Female Health Care, Cardiovascular, Imaging, Cancer Pain, Gastro Intestinal, and others allow him to comfortably understand and approach the many aspects of drug development. Throughout the years he has worked for the full spectrum of pharmaceutical companies; from large global companies like Warner Lambert/Pfizer, Schering AG/Bayer, Otsuka, and GSK to medium and small biotechnology companies like Alliance, and Eurand and covered various roles ranging from Associate Director to Vice President of Clinical Development and Operations.
    Angelo received his degree in medicine from the University or Rome (Italy) and has practiced medicine for a short period of time as Vascular Surgeon before starting his research activities in the United States at UCLA. He has also invented and co-invented products in the medical field (medicines and devices).


    Dr. Rena Patel, Chief Patent Counsel

    Dr. Rena Patel is a seasoned IP attorney and has been in practice since 1998. She is a graduate of Duquesne University (Ph.D.) and California Western School of Law (J.D.). She started her law career as an associate at Woodcock Washburn (now Baker Hostetler), progressing to Patent Counsel at Bristol-Myers Squibb Company, and Chief Patent Counsel – Oral Care at Colgate-Palmolive Company.

    Rena has significant global experience in IP practice having also been an independent consultant working with start-up ventures and multinational pharmaceutical companies in Europe and Asia. Rena has a strong interest in education and serves as the vice-president of the West Windsor-Plainsboro Education Foundation, which is a private, non-profit organization that supports excellence in the WW-P Regional Schools through innovative programs, strategic initiatives, and funding of grants for teachers.

    Shefali C. Khaladkar, AVP - Finance & Commercial

    Shefali is a Chartered Accountant having over 18 years of experience in Pharma Industry and Big Four, Advisory & Assurance services. In addition to her professional grooming with the Big Fours, she has an international experience and has worked in cross-border multi-cultural work environments. She has been with global organizations, viz, Fresenius Kabi, PricewaterhouseCoopers, KPMG and Deloitte. 

    She has been a Key Managerial Personnel with Fresenius Kabi (India) and has held various key positions during her tenure ranging from CFO for India entity and Chief Controller for Region India for Oncology & Standard Solutions business to Head of Internal Audit and Leading Treasury Operations in India. Her specialties include Planning, Budgeting & Forecasting (Strategic & Operational) including dealing with special situations such as business turnaround, Developing and implementing operational plan tracking mechanisms through specific measurable KPIs, Developing and monitoring Business Plans, Mergers & Acquisitions, Business Restructuring, Leading Cost Efficiency programs, Developing & Implementing Tax Efficient Business Models (including business valuations), Financial Controlling & Reporting (IGAAP, USGAAP), Acquisition integration with Global Standards, Cash Flow Management and Process Excellence.


    Copyright © 2015 Vyome Biosciences. All rights reserved.